IMPRIMED

imprimed-logo

Precision medicine for pets with cancer

#SimilarOrganizations #People #Financial #Website #More

IMPRIMED

Industry:
Biotechnology Health Care Medical Veterinary

Founded:
2017-05-04

Address:
Palo Alto, California, United States

Country:
United States

Website Url:
http://www.imprimedicine.com

Total Employee:
11+

Status:
Active

Email Addresses:
[email protected]

Total Funding:
11.73 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default LetsEncrypt Content Delivery Network Apache JsDelivr AJAX Libraries API BootstrapCDN Apache 2.4


Similar Organizations

disc-medicine-logo

Disc Medicine

Disc Medicine is a hematology company

elicio-therapeutics-logo

Elicio Therapeutics

Elicio Therapeutics develops an immuno-tumor vaccine to treat cancer.

endpoint-health-logo

Endpoint Health

Precision Immunology Therapies

epiclinic-logo

epiclinic

cosmetic medicine, health & beauty

nuchem-sciences-logo

NuChem Sciences

NuChem Sciences is a drug discovery in chemistry contract research organization (CRO) located in Montrรฉal and Lรฉvis.

pacylex-logo

Pacylex

Pacylex Pharmaceuticals develops a precision medicine solution for multiple common cancers.

pinpoint-pharma-logo

Pinpoint Pharma

Custom medicine for pets on demand

praxis-precision-medicines-logo

Praxis Precision Medicines

Praxis develops therapies for CNS disorders by leveraging genetic insights into neuronal imbalances, targeting rare to common conditions.

protean-biodiganostics-inc-logo

Protean BioDiganostics Inc

Precision Oncology and Diagnostics

scailyte-logo

Scailyte

True precision medicine through single-cell science

semma-therapeutics-logo

Semma Therapeutics

Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.


Current Advisors List

jamin-koo_image

Jamin Koo Co-Founder & Director @ ImpriMed
Board_member
2017-01-01

Current Employees Featured

sungwon-lim_image

Sungwon Lim
Sungwon Lim CEO & Co-Founder @ ImpriMed
CEO & Co-Founder
2017-05-01

Founder


hye-ryeon-lee_image

Hye Ryeon Lee

jamin-koo_image

Jamin Koo

sungwon-lim_image

Sungwon Lim

Investors List

mayo-clinic-platform_image

Mayo Clinic Platform

Mayo Clinic Platform investment in Seed Round - ImpriMed

murex-partners_image

Murex Partners

Murex Partners investment in Seed Round - ImpriMed

futureplay-co_image

FuturePlay

FuturePlay investment in Seed Round - ImpriMed

hg-initiative_image

HG Initiative

HG Initiative investment in Seed Round - ImpriMed

es-investor_image

ES Investor

ES Investor investment in Seed Round - ImpriMed

sazzepartners_image

Primer Sazze Partners

Primer Sazze Partners investment in Seed Round - ImpriMed

draper-associates-2_image

Draper Associates

Draper Associates investment in Seed Round - ImpriMed

draper-dragon_image

Draper Dragon

Draper Dragon investment in Seed Round - ImpriMed

sema-translink-investment_image

Translink Investment

Translink Investment investment in Seed Round - ImpriMed

bon-angels_image

Bon Angels Venture Partners

Bon Angels Venture Partners investment in Seed Round - ImpriMed

Official Site Inspections

http://www.imprimedicine.com Semrush global rank: 1.8 M Semrush visits lastest month: 12.73 K

Unable to get host informations!!!

Loading ...

More informations about "ImpriMed"

About Us - ImpriMed

ImpriMed's mission to empower clinicians and help patients with the best predictive information for personalized cancer careSee details»

ImpriMedicine

At ImpriMed, we understand how overwhelming it can be when your furry friend is diagnosed with lymphoma. That's why we offer advanced testing to help identify the most effective โ€ฆSee details»

ImpriMed - Crunchbase Company Profile & Funding

ImpriMed is a company that creates individualized drug response prediction technology to help veterinarians fight lymphoma. The company's technology โ€ฆSee details»

Human Oncology - ImpriMed

We first launched the ImpriMed platform in the veterinary oncology space which moves at a significantly higher speed than the human oncology market and allows easy access to comprehensive patient data. ImpriMed has helped 200+ โ€ฆSee details»

ImpriMedicine

New user? Create an accountEmailImpriMedicineSee details»

ImpriMed: Fighting Cancer โ€” From Dogs To Humans

Apr 6, 2021 ImpriMed is a biotech startup that innovates the way of cancer care based on science and medicine. Our mission is to help oncologists provide more tailored treatment approaches; based on data ...See details»

ImpriMed - Company Profile - Tracxn

Jan 18, 2025 ImpriMed - Provider of precision medicines for veterinary cancer. Raised a total funding of $34.9M over 5 rounds from 28 investors.See details»

ImpriMed Raises $23 Million Series A Round to Expand โ€ฆ

Dec 19, 2023 Series A round led by SBVA (SoftBank Ventures Asia) to help expand ImpriMedโ€™s services beyond veterinary medicine into human oncologySee details»

ImpriMed - YouTube

Our mission here at ImpriMed is to provide oncologists with the tools they need to make more informed decisions about their patientsโ€™ cancer care. In the process, we hope to be able to โ€ฆSee details»

ImpriMed Unveils Cancer Treatment Prediction Technology at EHA โ€ฆ

Sep 23, 2024 The company also plans to broaden its contract research organization (CRO) services, offering pharmaceutical companies access to ImpriMedโ€™s cutting-edge live-cell โ€ฆSee details»

Expert Oncology Services | Advanced Cancer Care โ€ฆ

ImpriMed is bringing together our expertise in humans and canines to accelerate the development of AI-driven solutions for all cancer patients.See details»

ImpriMedicine - Identifying personalized drug combinations

What we do Our product is a highly scalable, high-throughput drug-sensitivity assay kit for precision medicine ApplicationsSee details»

ImpriMedicine

Note: The email above will be used for sign in and all communications from the team at ImpriMed.ImpriMedicineSee details»

ImpriMed - Pet Care Innovation

ImpriMed helps veterinary oncologists personalize chemotherapy by providing a data-driven drug response prediction for individual cancer patients.See details»

Participate in Our Research - ImpriMedicine

Join us in our continuous research and development efforts to drive innovations in the field of veterinary oncology. Together, we can enhance cancer care and make a meaningful impact.See details»

ImpriMed Unveils Cancer Treatment Prediction Technology at

Sep 23, 2024 With our expansion into contract research organization services, we look forward to supporting the development of novel cancer therapies and more personalized treatments, โ€ฆSee details»

PowerPoint Presentation

Learn more at www.imprimedicine.com Sungwon Lim, Ph.D. ImpriMed, Inc. [email protected] We are looking for ... Partners Pharma companies Clinical trial โ€ฆSee details»

Terms of Service - ImpriMed

Jan 11, 2021 Our failure to insist upon or enforce strict performance of any provision of these Terms shall not be construed as a waiver of any right. Notices We may notify you via postings โ€ฆSee details»

Imprimedicine - GitHub

People This organization has no public members. You must be a member to see whoโ€™s a part of this organization.GitHub is where Imprimedicine builds software.See details»

Vet Portal | Streamlined Veterinary Lab Services Online

ImpriMed Vet Portal is a sample and test result management system that enables veterinarians to easily request our service, track progress, and access test results.See details»

linkstock.net © 2022. All rights reserved